Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3205-3221.e24
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 657-663
Open Access | Times Cited: 1734
Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 204
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194
Impact of the Human Cell Atlas on medicine
Jennifer Rood, Aidan Maartens, Anna Hupalowska, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2486-2496
Open Access | Times Cited: 137
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
Aurélien Sokal, Giovanna Barba‐Spaeth, I. Fernández, et al.
Immunity (2021) Vol. 54, Iss. 12, pp. 2893-2907.e5
Open Access | Times Cited: 125
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, et al.
Cell Reports (2021) Vol. 36, Iss. 13, pp. 109760-109760
Open Access | Times Cited: 102
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
Nature (2021)
Open Access | Times Cited: 97
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A. VanBlargan, Lucas J. Adams, Zhuoming Liu, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2399-2416.e6
Open Access | Times Cited: 94
Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
Lok Bahadur Shrestha, Nicodemus Tedla, Rowena A. Bull
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 75
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
Aaron J. Schmitz, Jackson S. Turner, Zhuoming Liu, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2159-2166.e6
Open Access | Times Cited: 63
A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
Xun Chen, Matteo Gentili, Nir Hacohen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 63
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 63
SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
Ping He, Banghui Liu, Xijie Gao, et al.
Nature Microbiology (2022) Vol. 7, Iss. 10, pp. 1635-1649
Open Access | Times Cited: 50
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Mingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
Chengcheng Fan, Alexander A. Cohen, Miso Park, et al.
Immunity (2022) Vol. 55, Iss. 12, pp. 2419-2435.e10
Open Access | Times Cited: 41
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Kang Wang, Yunlong Cao, Yunjiao Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 31
Structural Insights into the Design of Synthetic Nanobody Libraries
Mario S. Valdés‐Tresanco, Andrea Molina-Zapata, A. González, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2198-2198
Open Access | Times Cited: 30
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Qingrui Huang, Xiaonan Han, Jinghua Yan
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2412-2422
Open Access | Times Cited: 30
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
Alexander A. Cohen, Jennifer R. Keeffe, Ariën Schiepers, et al.
Cell (2024) Vol. 187, Iss. 20, pp. 5554-5571.e19
Open Access | Times Cited: 6
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
Alexander A. Cohen, Jennifer R. Keeffe, Ariën Schiepers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top